Maslovsky I, Uriev L, Lugassy G
Hematology Institute, Barzilai Medical Center, Ashkelon, Israel.
Am J Med Sci. 2000 Oct;320(4):292-5. doi: 10.1097/00000441-200010000-00013.
Castleman disease (CD; angiofollicular lymphoid hyperplasia) is a heterogeneous group of lymphoproliferative disorders of uncertain cause. Three histologic variants (hyaline vascular, plasma cell, and mixed) and two clinical types (localized and multicentric) of CD have been described. We report 5 cases of CD treated in our institute and review the literature about the management of this relatively rare disorder. Localized and multicentric CD may be different clinical disorders with overlapping histologic features. Localized disease generally presented with a single enlarged lymph node or widening of the mediastinum, whereas multicentric disease is a systemic lymphoproliferative disorder characterized by lymphadenopathy, hepatosplenomegaly, constitutional symptoms, anemia, hypoalbuminemia, and hypergammaglobulinemia. Unlike the localized type, for which surgical excision is curative regardless of the histologic type, multicentric disease often necessitates aggressive systemic therapy and portends a poorer outcome.
卡斯尔曼病(CD;血管滤泡性淋巴组织增生症)是一组病因不明的异质性淋巴增殖性疾病。已描述了CD的三种组织学变型(透明血管型、浆细胞型和混合型)和两种临床类型(局限性和多中心性)。我们报告了在我院接受治疗的5例CD病例,并回顾了有关这种相对罕见疾病治疗的文献。局限性和多中心性CD可能是具有重叠组织学特征的不同临床疾病。局限性疾病通常表现为单个肿大淋巴结或纵隔增宽,而多中心性疾病是一种系统性淋巴增殖性疾病,其特征为淋巴结病、肝脾肿大、全身症状、贫血、低白蛋白血症和高球蛋白血症。与局限性类型不同,局限性类型无论组织学类型如何,手术切除均可治愈,而多中心性疾病通常需要积极的全身治疗,且预后较差。